2m 2m 2m 2m 2m 2m 2m
Biomarin Pharm (BMRN)
NASDAQ
$65.67-$0.02 (-0.02%)
Price as of Sep 11, 2026 7:30 PM EDT- $12.7BMarket Cap
- 21.43%1-Year Change
- BiotechnologyIndustry
Biomarin Pharm (BMRN)
$65.67-$0.02 (-0.02%)
Earnings Score
Valuation | BMRN | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | BMRN | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 21.29% | ||
12-Month Momentum | 25.63% | ||
3-Month Risk Adjusted Momentum | 169.41% | ||
12-Month Risk Adjusted Momentum | 75.03% |
True Yield
Valuation | BMRN | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.06% | ||
Net Debt Paydown Yield | -19.43% |
Financial Health Score
Valuation | BMRN | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 6 |